NCT04185051View on ClinicalTrials.gov

A Study to Investigate the Effect of JNJ-67953964 on Gastric Mucosal Integrity in Healthy Male and Female Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

December 17, 2019

Primary Completion Date

April 21, 2021

Study Completion Date

May 5, 2021

Conditions
Healthy
Interventions
DRUG

JNJ-67953964

Participants will receive JNJ-67953964 as oral capsules.

DRUG

Placebo

Participants will receive matching placebo oral capsules.

Trial Locations (1)

2170

Clinical Pharmacology Unit, Merksem

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT04185051 - A Study to Investigate the Effect of JNJ-67953964 on Gastric Mucosal Integrity in Healthy Male and Female Participants | Biotech Hunter | Biotech Hunter